Some readers may have seen a recent report in the national newspapers of the case of a teenage girl with persistent severe headache associated with a fatal brain tumour having been undiagnosed despite many consultations with her medical advisers. It...
12 August 2020
| Yarrow Scantling-Birch
|
COVID-19
1. Alcon Experience Academy The Alcon Experience Academy ran a non-promotional educational series from 12 May to 23 June 2020. Being mildly biased as a junior trainee, this has to be rated by far the best series due to its...
Case report A 40-year-old Caucasian male presented with a four-day history of redness and progressive painless reduction of vision in the left eye. His visual acuities were 6/4 in the right and 6/36 in the left. The left eye showed...
Miller Fisher syndrome (MFS) is a rare, acquired nerve disease that is considered to be a variant of Guillain-Barré syndrome. It was first recognised by James Collier in 1932 as a clinical triad of ataxia, areflexia and ophthalmoplegia. Later, it...
12 August 2020
| Yarrow Scantling-Birch
|
COVID-19
1. Alcon Experience Academy The Alcon Experience Academy ran a non-promotional educational series from 12 May to 23 June 2020. Being mildly biased as a junior trainee, this has to be rated by far the best series due to its...
Assessment of optic nerve appearance and functions is a daily routine in neuro-ophthalmology. Following a recent high profile court case there has been a significant increase in the amount of referral to ophthalmology departments to assess the optic nerve and...
Eye research charity Fight for Sight has announced its latest project funding and its plans for continuing its efforts to advance eye research in the current global health crisis and beyond.
Government announces drive to digitise GP phonelines and offer greater options in patient access to care in dentistry and pharmacy, but does not capitalise on opportunities to improve patient experiences closer to home or address IT connectivity issues holding back optometry services.
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
“We are drowning in people we need to see in hospital eye services, and some people are going blind as a result. We are looking at nearly 10m hospital appointments for ophthalmology a year, with an approximately 33% increase over...
13 August 2020
| Elanor Watts, Victor Hu, Will Dean, John Buchan, John Nkurikiye, Mike Burdon, Josiah Onyango, Marcia Zondervan
|
COVID-19, Ophthalmology
The Royal College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) and the Royal College of Ophthalmologists (the Royal College) have had a successful VISION 2020 LINK partnership for over 12 years. The partnership was established by the VISION...